140 related articles for article (PubMed ID: 34045664)
21. Primary eccrine porocarcinoma of the finger with transit forearm and axillary metastasis.
Bhat W; Akhtar S; Khotwal A; Platt AJ
Ann Plast Surg; 2011 Apr; 66(4):344-6. PubMed ID: 21042176
[TBL] [Abstract][Full Text] [Related]
22. Eccrine porocarcinoma: case report and review of the literature.
Grieco M; Simonacci F; Grignaffini E; Ricci R; Raposio E
G Ital Dermatol Venereol; 2020 Aug; 155(4):500-504. PubMed ID: 33050682
[TBL] [Abstract][Full Text] [Related]
23. Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2.
Drohan A; Melvin J; Murphy J; Giacomantonio C; Helyer L
Curr Oncol; 2020 Dec; 28(1):220-225. PubMed ID: 33704189
[TBL] [Abstract][Full Text] [Related]
24. Eccrine porocarcinoma of the vulva: a case report and review of the literature.
Fujimine-Sato A; Toyoshima M; Shigeta S; Toki A; Kuno T; Sato I; Watanabe M; Niikura H; Yaegashi N
J Med Case Rep; 2016 Nov; 10(1):319. PubMed ID: 27832810
[TBL] [Abstract][Full Text] [Related]
25. Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.
Smeby J; Kryeziu K; Berg KCG; Eilertsen IA; Eide PW; Johannessen B; Guren MG; Nesbakken A; Bruun J; Lothe RA; Sveen A
EBioMedicine; 2020 Sep; 59():102923. PubMed ID: 32799124
[TBL] [Abstract][Full Text] [Related]
26. A case of eccrine porocarcinoma: A treacherous mimic and diagnostic challenge.
Das D; Datta C; Chatterjee U; De A
Indian J Pathol Microbiol; 2021; 64(1):186-188. PubMed ID: 33433439
[TBL] [Abstract][Full Text] [Related]
27. A case of eccrine porocarcinoma characterized by a progressive increase in the level of Ki-67 index: case report and review of literature.
Shen J; Pan X; Lu Y; Pan D; Ma Y; Zhan R
BMC Surg; 2019 Oct; 19(1):142. PubMed ID: 31601219
[TBL] [Abstract][Full Text] [Related]
28. Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature.
Song SS; Wu Lee W; Hamman MS; Jiang SI
Dermatol Surg; 2015 Mar; 41(3):301-6. PubMed ID: 25742554
[TBL] [Abstract][Full Text] [Related]
29. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
[TBL] [Abstract][Full Text] [Related]
30. [Eccrine porocarcinoma: report of four cases and literature review].
Mulinari-Brenner FA; Mukai MM; Bastos CA; Filho EA; Santamaria JR; Neto JF
An Bras Dermatol; 2009; 84(5):519-23. PubMed ID: 20098856
[TBL] [Abstract][Full Text] [Related]
31. Concomitant poroma and porocarcinoma.
Abarzúa Á; Álvarez-Véliz S; Moll-Manzur C
An Bras Dermatol; 2017; 92(4):550-552. PubMed ID: 28954110
[TBL] [Abstract][Full Text] [Related]
32. Eccrine poroma and porocarcinoma on the same unusual location: report on two cases.
Ma H; Liao M; Qiu S; Lu R; Lu C
An Bras Dermatol; 2015; 90(3 Suppl 1):69-72. PubMed ID: 26312678
[TBL] [Abstract][Full Text] [Related]
33. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
Bosic M; Kirchner M; Brasanac D; Leichsenring J; Lier A; Volckmar AL; Oliveira C; Buchhalter I; Stögbauer F; Zivkovic-Perisic S; Goeppert B; Schirmacher P; Penzel R; Endris V; Stenzinger A
Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
[TBL] [Abstract][Full Text] [Related]
34. Porocarcinoma: case report.
Cursino FD; Teixeira L; Lima Ede A; Lima Mde A; Rodrigues SC; Takano D
An Bras Dermatol; 2011; 86(6):1201-4. PubMed ID: 22281914
[TBL] [Abstract][Full Text] [Related]
35. Identification of Targetable Lesions in Anaplastic Thyroid Cancer by Genome Profiling.
Ravi N; Yang M; Gretarsson S; Jansson C; Mylona N; Sydow SR; Woodward EL; Ekblad L; Wennerberg J; Paulsson K
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30909364
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of p16 and RB protein in eccrine porocarcinoma.
Gu LH; Ichiki Y; Kitajima Y
J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741
[TBL] [Abstract][Full Text] [Related]
37. FDG PET/CT in malignant eccrine porocarcinoma arising in a pre-existing poroma.
Golemi A; Hanspeter E; Brugger E; Ruiu A; Farsad M
Clin Nucl Med; 2014 May; 39(5):456-8. PubMed ID: 23917787
[TBL] [Abstract][Full Text] [Related]
38. Eccrine porocarcinoma (malignant eccrine poroma): a series of eight challenging cases.
Luz Mde A; Ogata DC; Montenegro MF; Biasi LJ; Ribeiro LC
Clinics (Sao Paulo); 2010 Jul; 65(7):739-42. PubMed ID: 20668633
[No Abstract] [Full Text] [Related]
39. [Sweat gland eccrine porocarcinoma of the face: a rare annexal tumor].
Lakouichmi M; El Bouihi M; Zrara I; Lahmiti S; Hattab NM
Pan Afr Med J; 2013; 14():135. PubMed ID: 23734280
[TBL] [Abstract][Full Text] [Related]
40. [Eccrine porocarcinoma with Bowenoid changes: a challenging diagnosis of adnexal neoplasm].
Kottler D; Rivet J; Hickman G; Comte C; Duron JB; Basset-Seguin N; Lebbe C; Bagot M; Janin A
Ann Pathol; 2014 Oct; 34(5):378-83. PubMed ID: 25439991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
